Neratinib Plus Capecibine in Patients With HER2-Positive Metastatic Breast Cancer

J Clin Oncol. 2021 Jan 20;39(3):252-253. doi: 10.1200/JCO.20.02378. Epub 2020 Dec 17.

Authors

Dun-Chang Mo¹, Peng-Hui Luo¹, Jian-Feng Huang¹, Shang-Xiao Huang¹, Han-Lei Wang¹

Affiliation

¹ Dun-Chang Mo, MD, Peng-Hui Luo, MD, Jian-Feng Huang, MD, Shang-Xiao Huang, MD, and Han-Lei Wang, MD, Radiotherapy Department, Nanning Second Peoples Hospital, Nanning, Guangxi, China.

PMID: 33332194
DOI: 10.1200/JCO.20.02378

No abstract available

Publication types

Letter
Comment

MeSH terms

Breast Neoplasms* / drug therapy
Breast Neoplasms* / genetics
Female
Humans
Quinolines*
Receptor, ErbB-2

Substances

Quinolines
Receptor, ErbB-2
neratinib